Physician profile
Howard J Marcus
NPI 1972585842
$3,369.01
in general payments reported to CMS, 2019-2025
26 companies · $291 in 2025
The $291 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,225 · 2020: $89.23 · 2021: $123 · 2022: $323 · 2023: $143 · 2024: $174 · 2025: $291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $609.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $608.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,008.05 | 2019 | |
| Abbvie INC. | $219.16 | 2019-2021 | |
| Coopersurgical, INC. | $188.46 | 2019-2025 | Paragard T 380a |
| Astellas Pharma US INC | $116.60 | 2022-2025 | Veozah, Myrbetriq |
| Baxter Healthcare | $113.66 | 2022-2025 | Perclot, Floseal |
| Hologic Sales and Service, LLC | $96.38 | 2019-2025 | Coolseal Generator |
| Mayne Pharma Commercial LLC | $89.44 | 2023-2025 | |
| Exeltis, USA INC. | $81.88 | 2019-2024 | Slynd |
| Sumitomo Pharma America, INC. | $42.41 | 2023-2024 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $42.00 | 2021-2024 | |
| Exact Sciences Corporation | $36.83 | 2025 | Cologuard Collection Kit |
| Lsi Solutions INC | $33.58 | 2019 | |
| Pfizer INC. | $32.87 | 2019-2022 | |
| Organon LLC | $30.47 | 2024 | |
| Meditrina | $26.92 | 2022-2025 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $25.07 | 2025 | Arista |
| Organogenesis INC. | $24.40 | 2025 | Puraply Wound Matrix |
| Ethicon US, LLC | $24.35 | 2025 | Vistaseal, Ethicon |
| Merck Sharp & Dohme LLC | $19.52 | 2019 | |
| Gynesonics, INC. | $18.76 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Myovant Sciences INC. | $18.44 | 2021 | |
| Biogen, INC. | $17.61 | 2025 | Zurzuvae |
| Amag Pharmaceuticals, INC. | $17.44 | 2019 | |
| Agile Therapeutics, INC. | $17.32 | 2022 | |
| Shield Therapeutics INC | $13.84 | 2024 | |
| Avion Pharmaceuticals | $13.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Marcus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.